<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: Serum brain natriuretic <z:chebi fb="7" ids="16670">peptide</z:chebi> (BNP) is elevated after <z:hpo ids='HP_0002138'>subarachnoid hemorrhage</z:hpo> (SAH), causes <z:mp ids='MP_0001762'>diuresis</z:mp> and <z:mp ids='MP_0006316'>natriuresis</z:mp> (cerebral <z:hpo ids='HP_0000127'>salt wasting</z:hpo>), and may exacerbate delayed ischemic neurological deficits </plain></SENT>
<SENT sid="1" pm="."><plain>We examined the temporal relationship between serum BNP elevation, <z:hpo ids='HP_0002902'>hyponatremia</z:hpo>, and the <z:hpo ids='HP_0003674'>onset</z:hpo> of delayed ischemic neurological deficits and determined whether serum BNP levels correlated with the 2-week outcome after SAH </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: Serum BNP and <z:chebi fb="199" ids="26708">sodium</z:chebi> were measured prospectively every 12 hours for 14 days in 40 consecutive patients admitted with SAH </plain></SENT>
<SENT sid="3" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> patients remained euvolemic, underwent transcranial Doppler assessment every 48 hours, and underwent angiography at the <z:hpo ids='HP_0003674'>onset</z:hpo> of delayed neurological deficits </plain></SENT>
<SENT sid="4" pm="."><plain>New-<z:hpo ids='HP_0003674'>onset</z:hpo> neurological deficits were attributed to vasospasm only in the absence of other causes and when supported by transcranial Doppler or cerebral angiography </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: Sixteen patients (40%) experienced symptomatic <z:e sem="disease" ids="C0265110" disease_type="Disease or Syndrome" abbrv="">cerebral vasospasm</z:e> after SAH </plain></SENT>
<SENT sid="6" pm="."><plain>A more than threefold increase in admission serum BNP was associated with the <z:hpo ids='HP_0003674'>onset</z:hpo> of <z:hpo ids='HP_0002902'>hyponatremia</z:hpo> (P &lt; 0.05) </plain></SENT>
<SENT sid="7" pm="."><plain>Mean BNP levels were similar between vasospasm and nonvasospasm patients fewer than 3 days after SAH (126 +/- 39 pg/ml versus 154 +/- 40 pg/ml; P = 0.61) but were elevated in the vasospasm cohort 4 to 6 days after SAH (285 +/- 67 pg/ml versus 116 +/- 30 pg/ml; P &lt; 0.01), 7 to 9 days after SAH (278 +/- 72 pg/ml versus 166 +/- 45 pg/ml; P &lt; 0.01), and 9 to 12 days after SAH (297 +/- 83 pg/ml versus 106 +/- 30 pg/ml; P &lt; 0.01) </plain></SENT>
<SENT sid="8" pm="."><plain>BNP level remained independently associated with vasospasm adjusting for Fisher grade and Hunt and Hess grade (odds ratio, 1.28; 95% confidence interval, 1.1-1.6) </plain></SENT>
<SENT sid="9" pm="."><plain>In patients in whom vasospasm developed, mean serum BNP increased 5.4-fold within 24 hours after vasospasm <z:hpo ids='HP_0003674'>onset</z:hpo> and 11.2-fold the first 3 days after vasospasm <z:hpo ids='HP_0003674'>onset</z:hpo> </plain></SENT>
<SENT sid="10" pm="."><plain>Patients with increasing BNP levels from admission demonstrated no change (0 +/- 3) in Glasgow <z:hpo ids='HP_0001259'>Coma</z:hpo> Scale score 2 weeks after SAH versus a 3.0 +/- 2 (P &lt; 0.05) improvement in Glasgow <z:hpo ids='HP_0001259'>Coma</z:hpo> Scale score in patients without increasing serum BNP levels </plain></SENT>
<SENT sid="11" pm="."><plain>CONCLUSION: Increasing serum BNP levels independently were associated with <z:hpo ids='HP_0002902'>hyponatremia</z:hpo>, significantly increased the first 24 hours after <z:hpo ids='HP_0003674'>onset</z:hpo> of delayed ischemic neurological deficits, and predicted the 2-week Glasgow <z:hpo ids='HP_0001259'>Coma</z:hpo> Scale score </plain></SENT>
</text></document>